BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27999200)

  • 1. Metalloproteinase meprin α regulates migration and invasion of human hepatocarcinoma cells and is a mediator of the oncoprotein Reptin.
    Breig O; Yates M; Neaud V; Couchy G; Grigoletto A; Lucchesi C; Prox J; Zucman-Rossi J; Becker-Pauly C; Rosenbaum J
    Oncotarget; 2017 Jan; 8(5):7839-7851. PubMed ID: 27999200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reptin regulates DNA double strand breaks repair in human hepatocellular carcinoma.
    Raymond AA; Benhamouche S; Neaud V; Di Martino J; Javary J; Rosenbaum J
    PLoS One; 2015; 10(4):e0123333. PubMed ID: 25875766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATPase activity of reptin is required for its effects on tumor cell growth and viability in hepatocellular carcinoma.
    Grigoletto A; Neaud V; Allain-Courtois N; Lestienne P; Rosenbaum J
    Mol Cancer Res; 2013 Feb; 11(2):133-9. PubMed ID: 23233483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reptin regulates insulin-stimulated Akt phosphorylation in hepatocellular carcinoma via the regulation of SHP-1/PTPN6.
    Raymond AA; Javary J; Breig O; Neaud V; Rosenbaum J
    Cell Biochem Funct; 2017 Aug; 35(6):289-295. PubMed ID: 28833338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloproteases meprin-ɑ (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer.
    Wang X; Chen J; Wang J; Yu F; Zhao S; Zhang Y; Tang H; Peng Z
    BMC Cancer; 2016 Jul; 16():383. PubMed ID: 27378469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
    OuYang HY; Xu J; Luo J; Zou RH; Chen K; Le Y; Zhang YF; Wei W; Guo RP; Shi M
    Hepatology; 2016 Apr; 63(4):1227-39. PubMed ID: 26660154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism.
    Tang JC; Liu JH; Liu XL; Liang X; Cai XJ
    World J Gastroenterol; 2015 Oct; 21(39):11127-40. PubMed ID: 26494967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma.
    Ju L; Li X; Shao J; Lu R; Wang Y; Bian Z
    Oncol Rep; 2018 Dec; 40(6):3794-3802. PubMed ID: 30542731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism.
    Haurie V; Ménard L; Nicou A; Touriol C; Metzler P; Fernandez J; Taras D; Lestienne P; Balabaud C; Bioulac-Sage P; Prats H; Zucman-Rossi J; Rosenbaum J
    Hepatology; 2009 Dec; 50(6):1871-83. PubMed ID: 19877184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo silencing of Reptin blocks the progression of human hepatocellular carcinoma in xenografts and is associated with replicative senescence.
    Ménard L; Taras D; Grigoletto A; Haurie V; Nicou A; Dugot-Senant N; Costet P; Rousseau B; Rosenbaum J
    J Hepatol; 2010 May; 52(5):681-9. PubMed ID: 20346530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
    Meng F; Henson R; Wehbe-Janek H; Ghoshal K; Jacob ST; Patel T
    Gastroenterology; 2007 Aug; 133(2):647-58. PubMed ID: 17681183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HEATR1, a novel interactor of Pontin/Reptin, stabilizes Pontin/Reptin and promotes cell proliferation of oral squamous cell carcinoma.
    Nakamura A; Kakihara Y; Funayama A; Haga K; Mikami T; Kobayashi D; Yoshida Y; Izumi K; Kobayashi T; Saeki M
    Biochem Biophys Res Commun; 2021 Jun; 557():294-301. PubMed ID: 33894417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P4HB promotes HCC tumorigenesis through downregulation of GRP78 and subsequent upregulation of epithelial-to-mesenchymal transition.
    Xia W; Zhuang J; Wang G; Ni J; Wang J; Ye Y
    Oncotarget; 2017 Jan; 8(5):8512-8521. PubMed ID: 28052026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
    Yang F; Lv LZ; Cai QC; Jiang Y
    World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHSY1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway.
    Liu CH; Lan CT; Chou JF; Tseng TJ; Liao WC
    Cancer Lett; 2017 Sep; 403():280-288. PubMed ID: 28652022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.